dengu
viru
denv
preval
mosquitoborn
viru
caus
diseas
human
estim
million
annual
infect
worldwid
million
manifest
clinic
symptom
dengu
diseas
may
present
nonspecif
febril
ill
sever
infect
mark
hemorrhag
circulatori
failur
denv
flaviviru
exist
distinct
serotyp
transmit
aed
mosquito
amino
acid
level
denv
serotyp
share
limit
similar
among
serotyp
similar
within
given
serotyp
epidemiolog
studi
report
differ
serotyp
regard
diseas
sever
notabl
secondari
infect
associ
sever
diseas
infect
correl
mild
diseas
hematopoiet
cell
myeloid
lineag
monocyt
macrophag
dc
primari
target
denv
infect
replic
dissemin
immatur
dc
peripheri
effici
captur
antigen
via
phagocytosi
macropinocytosi
upon
interact
infecti
agent
immatur
dc
subsequ
matur
process
includ
dc
surfac
remodel
increas
antigen
present
product
numer
cytokin
matur
dc
upregul
chemokin
receptor
eg
aid
migrat
lymph
node
well
costimulatori
molecul
eg
requir
activ
antigenspecif
cell
lymph
node
induc
cell
prolifer
effector
function
way
dc
key
player
link
innat
adapt
immun
therefor
abil
virus
modul
innat
immun
cell
signific
affect
viral
replic
dissemin
pathogenesi
peripher
blood
mononuclear
cell
healthi
blood
donor
use
gener
monocytederiv
dc
cell
product
infect
denv
primari
human
ex
vivo
dengu
viru
denv
preval
mosquitoborn
viru
caus
human
diseas
denv
serotyp
epidemiolog
data
suggest
secondari
infect
associ
sever
diseas
infect
mass
cytometri
timeofflight
cytof
use
dissect
immun
chang
induc
human
dc
initi
target
primari
infect
like
affect
infect
outcom
strikingli
replic
peak
earlier
promot
stronger
innat
immun
respons
increas
express
dc
activ
migrat
marker
increas
cytokin
product
compar
addit
infect
dc
produc
higher
level
inflammatori
cytokin
compar
bystand
dc
mainli
produc
ifninduc
cytokin
highdimension
analys
infect
reveal
distinct
viral
signatur
mark
differ
replic
strategi
antivir
innat
immun
induct
dc
may
result
differ
viral
fit
transmiss
pathogenesi
model
studi
primari
denv
infect
investig
effect
denv
infect
dc
activ
function
cytokin
product
denv
infect
observ
patient
vitro
nevertheless
pathogen
versu
protect
role
cytokin
denv
infect
complet
understood
propos
cytokin
storm
result
increas
vascular
permeabl
sever
diseas
howev
conflict
report
whether
cytokin
well
regulatori
cytokin
promot
pathogenesi
confer
protect
denv
infect
addit
group
other
demonstr
strain
inhibit
type
ifn
product
signal
impair
cell
polar
may
prevent
protect
adapt
immun
respons
studi
util
mass
cytometri
timeofflight
cytof
investig
effect
denv
infect
human
dc
unlik
flow
cytometri
requir
compens
overlap
fluoresc
spectra
cytof
use
antibodi
label
element
isotop
larg
unencumb
interfer
spectral
overlap
channel
current
cytof
allow
singlecel
analysi
paramet
simultan
power
technolog
yet
use
character
infect
denv
hemorrhag
fever
virus
simultan
investig
denv
infect
dc
activ
intracellular
cytokin
product
apoptosi
well
differ
bystand
infect
cell
dc
cultur
importantli
investig
viral
replic
subsequ
host
innat
immun
respons
provid
insight
fit
strategi
use
vectorborn
virus
like
denv
remain
circul
induc
vari
degre
diseas
sever
human
herein
provid
comprehens
function
analysi
compar
dc
infect
phylogenet
distant
serotyp
associ
differ
diseas
sever
show
display
differ
replic
strategi
induc
differ
antivir
innat
immun
respons
human
dc
may
relat
differ
viral
fit
transmiss
pathogenesi
replic
differ
studi
infect
human
donormatch
dc
moi
viral
isol
use
repres
preval
genotyp
serotyp
supplement
figur
supplement
materi
avail
onlin
articl
http
use
cytof
analysi
measur
intracellular
denv
structur
nonstructur
protein
titrat
extracellular
infecti
denv
particl
found
peak
infect
occur
hour
infect
hpi
wherea
infect
peak
hpi
significantli
diminish
hpi
figur
ad
notabl
infect
result
greater
percentag
infect
dc
compar
infect
figur
b
interestingli
despit
signific
differ
percentag
infect
cell
figur
differ
infect
kinet
figur
peak
titer
infecti
particl
releas
extracellularli
similar
figur
addit
even
though
infect
smaller
percentag
cell
compar
dc
infect
show
significantli
higher
level
denv
nonstructur
protein
figur
hpi
compar
dc
infect
togeth
data
suggest
infect
fewer
dc
later
infect
infect
cell
produc
mani
infecti
particl
wherea
infect
dc
earlier
infect
infect
cell
produc
fewer
infecti
particl
also
compar
replic
kinet
mosquito
cell
use
cell
aed
aegypti
cell
line
observ
compar
replic
kinet
time
cours
figur
particular
rapid
peak
subsequ
declin
titer
dc
infect
observ
mosquito
cell
thu
virus
differ
replic
kinet
presum
differ
viral
fit
strategi
human
dc
mosquito
cell
differenti
effect
infect
dc
phenotyp
function
fulli
appreci
dc
phenotyp
function
denv
infect
three
distinct
yet
complementari
techniqu
employ
analyz
cytof
data
global
view
dc
phenotyp
demonstr
heat
map
util
autog
strategi
analys
appar
dc
infect
led
signific
upregul
dc
activ
marker
well
cytokin
chemokin
ie
compar
mock
treatment
figur
notabl
dc
infect
demonstr
statist
signific
differ
express
cleav
marker
apoptosi
level
cell
death
supplement
figur
addit
visn
analysi
infect
notabl
cluster
cell
express
high
level
denv
envelop
denv
e
protein
cell
limit
one
phenotyp
figur
interestingli
cell
express
high
level
correspond
cluster
denv
eexpress
cell
figur
supplement
figur
express
broadli
distribut
also
larg
coloc
region
visn
plot
figur
supplement
figur
contrast
cell
highli
express
correspond
denv
eexpress
cell
figur
peak
infect
small
number
cell
express
high
level
denv
e
visibl
distribut
throughout
visn
plot
figur
supplement
figur
addit
notabl
upregul
dc
infect
compar
mock
treatment
figur
supplement
figur
interestingli
dc
costimulatori
marker
well
dc
migrat
marker
display
entir
differ
pattern
cell
express
high
level
marker
local
distinct
region
plot
express
high
level
cytokin
clear
later
time
point
infect
figur
supplement
figur
indic
cell
upregul
cytokin
distinct
upregul
high
level
dc
matur
marker
denv
infect
consist
hierarch
cluster
analysi
autog
cytof
data
figur
cytokin
cluster
close
denv
antigen
cytokin
farther
dc
phenotyp
function
marker
addit
visn
analysi
cell
express
high
level
cleav
marker
apoptosi
larg
local
distinct
cluster
repres
anoth
distinct
group
cell
respond
denv
infect
figur
supplement
figur
altogeth
data
indic
respons
denv
infect
dc
cell
cultur
heterogen
distinct
cellular
phenotyp
associ
cell
express
viral
antigen
heat
map
compar
cellular
marker
posit
denot
cell
either
posit
neg
marker
mock
dengu
viru
infect
plot
marker
order
vertic
hierarch
cluster
row
place
marker
similar
express
profil
closer
togeth
statist
signific
determin
use
fisher
exact
test
threshold
bonferroni
correct
multipl
test
cellular
marker
repres
signific
differ
infect
condit
threshold
label
ns
other
signific
calcul
made
use
event
count
mass
cytometri
timeofflight
cytof
data
determin
autog
cell
posit
marker
base
percentil
threshold
set
mock
treatment
hour
infect
hpi
compar
effect
marker
calcul
log
rel
risk
posit
marker
frequenc
indic
infect
condit
histogram
within
heat
map
color
scale
show
total
number
cell
match
intens
rang
reveal
overal
distribut
valu
one
repres
dc
donor
seven
shown
entir
popul
dc
sampl
power
cytof
analysi
includ
possibl
distinguish
infect
bystand
cell
within
sampl
allow
us
interrog
specif
contribut
bystand
versu
denvinfect
cell
use
marker
indic
denv
infect
ie
denv
e
protein
notabl
variou
pattern
observ
infect
bystand
cell
similar
infect
gener
dc
activ
marker
similarli
upregul
denvinfect
bystand
cell
follow
infect
dc
cultur
figur
hand
dc
show
increas
product
cell
compar
respect
bystand
cell
figur
b
remark
notabl
even
despit
low
number
cell
product
gener
similar
denvinfect
bystand
cell
except
earli
time
point
cell
demonstr
greater
percentag
cell
compar
bystand
cell
figur
interestingli
consist
role
ifnstimul
gene
isg
produc
primarili
bystand
cell
compar
cell
hpi
effect
pronounc
cultur
figur
thu
proinflammatori
cytokin
chemokin
isg
demonstr
distinct
pattern
product
denvinfect
versu
bystand
dc
addit
dc
demonstr
higher
percentag
cleav
cell
compar
respect
bystand
cell
later
time
point
suggest
greater
level
apoptosi
denvinfect
cell
figur
notabl
time
observ
consist
kinet
infect
two
virus
cytokin
secret
versu
infect
addit
intracellular
cytokin
analys
cytof
multiplex
elisa
perform
evalu
extracellular
cytokin
secret
dc
denv
infect
consist
prior
result
infect
induc
minim
low
level
secret
figur
contrast
infect
dc
induc
greater
secret
compar
mock
infect
infect
dc
figur
infect
also
induc
greater
secret
sever
proinflammatori
cytokin
chemokin
ie
rant
compar
mock
infect
figur
note
infect
induc
secret
sever
proinflammatori
cytokin
chemokin
compar
mock
infect
lesser
extent
infect
figur
continu
upregul
cytokin
chemokin
product
infect
appear
replic
depend
sinc
infect
dc
either
uvinactiv
uvinactiv
produc
infecti
particl
result
lower
level
cytokin
chemokin
secret
eg
rant
mig
later
time
point
compar
infect
respect
replicationcompet
denv
supplement
figur
observ
differ
cytokin
chemokin
product
could
theoret
due
differ
proport
infect
cell
cultur
two
virus
address
possibl
infect
dc
differ
moi
yield
similar
percentag
infect
cell
respect
peak
titer
supplement
figur
found
cytokin
chemokin
secret
infect
gener
moi
depend
greater
cytokin
chemokin
secret
higher
moi
supplement
figur
nevertheless
even
dc
infect
high
moi
cytokin
chemokin
eg
rant
mig
still
secret
higher
level
infect
moi
time
point
supplement
figur
togeth
data
suggest
level
cytokin
chemokin
secret
depend
less
viral
load
moi
inher
strain
differ
two
viru
strain
human
immun
respons
induc
infect
denv
hemorrhag
fever
virus
complex
character
high
level
proinflammatori
cytokin
chemokin
cytof
allow
simultan
examin
viral
infect
dc
activ
cytokin
product
apoptosi
individu
cell
work
provid
comprehens
detail
analysi
infect
kinet
immun
respons
induc
strain
human
dc
reveal
distinct
viral
signatur
knowledg
first
studi
util
cytof
examin
cell
infect
hemorrhag
fever
viru
interestingli
strain
show
markedli
differ
replic
kinet
human
dc
replic
similarli
mosquito
cell
figur
strain
also
capabl
activ
human
dc
upregul
dc
migrat
marker
induc
cytokin
product
compar
strain
therefor
postul
may
better
adapt
prolong
viru
replic
mosquito
compar
human
cell
wherea
may
well
adapt
prolong
replic
host
earli
burst
replic
may
suffici
produc
necessari
level
viremia
human
host
allow
earli
transmiss
back
mosquito
human
immun
respons
effect
clear
infect
therebi
prevent
continu
inflammatori
respons
caus
sustain
viral
replic
viral
fit
strategi
could
enabl
continu
circul
without
caus
sever
diseas
infect
human
contrast
strain
infect
rel
cell
induc
robust
innat
immun
respons
human
dc
way
may
effici
evad
human
immun
respons
caus
prolong
viremia
human
host
ensur
later
transmiss
back
mosquito
addit
limit
induct
innat
immun
infect
may
lead
ineffici
adapt
immun
respons
greater
epidem
potenti
data
present
work
therebi
support
epidemiolog
studi
show
infect
gener
result
milder
diseas
human
compar
pronounc
differ
immun
respons
induc
denv
serotyp
illustr
import
continu
investig
uniqu
qualiti
denv
serotyp
better
character
denvinduc
immun
respons
pathogenesi
furthermor
sinc
repres
denv
strain
use
studi
isol
mani
year
ago
therefor
undergon
numer
passag
laboratori
futur
studi
import
test
multipl
strain
denv
serotyp
includ
contemporari
strain
lowpassag
human
isol
test
hypothes
minim
effect
possibl
viral
adapt
occur
passag
tissu
cultur
addit
futur
studi
investig
blood
sampl
dengueinfect
patient
correl
viru
replic
immun
profil
denv
serotyp
diseas
sever
mani
differ
two
denv
serotyp
may
account
observ
differ
replic
immun
induct
human
cell
test
futur
studi
first
shown
predominantli
locat
cytoplasm
wherea
predominantli
locat
nuclei
infect
cell
sinc
denv
replic
take
place
cytoplasm
may
correl
avail
polymeras
molecul
replic
cytoplasm
earlier
peak
replic
kinet
addit
differ
denv
nuclear
local
may
affect
splice
host
rna
involv
immun
respons
viru
infect
addit
region
denv
untransl
region
one
least
conserv
region
denv
genom
among
serotyp
due
differ
region
like
produc
differ
subgenom
flaviviru
rna
sfrna
propos
sfrna
accumul
associ
viral
epidemiolog
fit
particular
strain
greater
sfrna
product
rel
viral
genom
rna
correl
epidemiolog
fit
also
shown
sfrna
antagon
human
innat
immun
pathway
decreas
ifn
isg
product
furthermor
recent
found
differ
denv
sfrna
speci
accumul
vertebr
invertebr
host
host
chang
subsequ
implic
innat
immun
respons
viral
fit
would
therefor
interest
determin
differ
sfrna
could
account
differ
regard
innat
immun
induct
viral
fit
host
adapt
human
mosquito
addit
visn
analysi
studi
elucid
demonstr
dc
produc
highest
amount
cytokin
larg
distinct
upregul
highest
amount
dc
activ
marker
denv
infect
figur
supplement
figur
consist
hierarch
cluster
analysi
autog
cytof
data
cytokin
tend
cluster
close
cytokin
denv
antigen
distinct
branch
dc
phenotyp
function
marker
figur
suggest
express
differ
cytokin
may
driven
signal
pathway
transcript
program
similar
one
anoth
less
similar
regul
dc
surfac
marker
express
follow
denv
infect
addit
compar
overal
effect
infect
strain
also
stratifi
cytof
data
quantit
compar
effect
denv
infect
cell
bystand
cell
dc
cultur
exist
studi
shown
differenti
effect
infect
bystand
cell
versu
infect
cell
cultur
uniqu
cytof
studi
use
marker
simultan
provid
comprehens
data
chang
dc
phenotyp
function
well
better
tempor
resolut
follow
infect
consist
prior
data
observ
dc
infect
strain
preferenti
produc
bystand
dc
preferenti
produc
figur
interestingli
data
also
show
type
ifn
secret
higher
level
infect
dc
compar
infect
dc
figur
thu
like
cell
produc
type
ifn
induc
product
isg
bystand
cell
bystand
cell
unabl
block
ifn
signal
sinc
contain
denv
protein
degrad
infect
cell
data
also
agreement
literatur
show
infect
induc
robust
type
ifn
respons
human
dc
hand
observ
cell
respect
bystand
cell
upregul
costimulatori
molecul
compar
mockinfect
dc
consist
prior
work
upregul
observ
studi
infect
bystand
cell
infect
suggest
bystand
dc
could
migrat
drain
lymph
node
vivo
infect
sinc
observ
infect
bystand
dc
capabl
activ
bystand
dc
like
undergo
cytokinemedi
matur
note
shown
cytokineinduc
matur
dc
subsequ
neoantigen
puls
promot
dc
prime
naiv
cell
toward
respons
furthermor
found
denvinfect
cell
preferenti
undergo
apoptosi
determin
cleav
express
compar
bystand
cell
time
consist
viral
replic
infect
figur
consist
work
show
sustain
denv
infect
may
lead
greater
induct
apoptosi
cell
undergo
apoptosi
may
releas
viral
progeni
contribut
viru
spread
may
releas
apoptot
bodi
later
engulf
dc
may
lead
bystand
dc
matur
also
possibl
loss
denvinfect
dc
apoptosi
could
impair
connect
innat
adapt
immun
therebi
diminish
human
immun
respons
denv
infect
data
demonstr
samplewid
populationstratifi
analys
valuabl
yield
differ
insight
immunolog
consequ
viral
infect
data
clearli
demonstr
denv
infect
induc
import
phenotyp
chang
infect
bystand
cell
like
contribut
overal
immun
respons
viral
infect
furthermor
data
illustr
even
small
number
denvinfect
cell
contribut
differ
respons
work
concert
previou
data
literatur
suggest
follow
model
dermal
dc
langerhan
cell
primari
cell
infect
denv
follow
bite
infect
mosquito
infect
dc
secret
proinflammatori
cytokin
chemokin
result
influx
monocyt
dermi
differenti
dc
becom
new
target
denv
replic
infect
dc
undergo
activ
matur
character
upregul
marker
cytokin
product
eg
denvinfect
cell
activ
bystand
dc
caus
matur
upregul
immun
stimuli
defect
viral
particl
denvinfect
dcderiv
exosom
contain
viral
compon
could
also
activ
bystand
cell
infect
bystand
dc
abl
migrat
drain
lymph
node
interact
cell
bystand
cell
could
also
abort
infect
could
captur
denv
antigen
via
phagocytosi
exosom
contain
denv
antigen
antigen
would
miss
antibodi
use
measur
activ
replic
assay
thu
possibl
bystand
cell
may
still
abl
present
denv
antigen
cell
lymph
node
hand
also
possibl
bystand
cell
may
acquir
denv
antigen
migrat
drain
lymph
node
may
interfer
cell
prime
denvinfect
dc
magnitud
type
ifn
product
dc
may
also
contribut
abil
dc
prime
cell
lymph
node
toward
respons
way
infect
dc
strain
result
greater
product
may
effici
skew
adapt
immun
respons
toward
respons
compar
infect
strain
altogeth
studi
illustr
power
util
cytof
examin
complex
immun
phenotyp
follow
viru
infect
inde
use
technolog
provid
insight
differ
serotyp
bystand
cell
versu
infect
cell
data
also
postul
differ
denv
strain
use
differ
replic
strategi
produc
suffici
high
viremia
transmiss
back
mosquito
vector
differ
replic
also
greatli
affect
innat
immun
induct
host
final
work
may
provid
use
framework
investig
emerg
virus
particular
arbovirus
like
chikungunya
viru
zika
viru
caus
recent
epidem
investig
differ
replic
strategi
use
vectorborn
virus
consequenti
immun
induct
host
may
provid
insight
differ
fit
strategi
vectorborn
virus
use
remain
circul
data
avail
http
immportorg
studi
access
cell
line
babi
hamster
kidney
bhk
cell
origin
obtain
sujan
shresta
la
jolla
institut
allergi
immunolog
la
jolla
california
usa
cultur
glutamax
supplement
vv
fb
uml
penicillin
streptomycin
mm
hepe
tissu
cultur
reagent
purchas
thermo
fisher
scientif
aed
aegypti
cell
gift
raul
andino
univers
california
san
francisco
san
francisco
california
usa
maintain
leibovitz
media
thermo
fisher
scientif
supplement
vv
tryptos
phosphat
broth
mm
lglutamin
mm
mem
nonessenti
amino
acid
sigmaaldrich
uml
penicillin
streptomycin
vv
fb
thermo
fisher
scientif
humidifi
atmospher
without
co
aed
albopictu
cell
origin
obtain
jorg
munozjordan
center
diseas
control
prevent
san
juan
puerto
rico
maintain
rpmi
media
invitrogen
supplement
mv
sodium
bicarbon
sigmaaldrich
mem
nonessenti
amino
acid
mm
lglutamin
mm
sodium
pyruv
vv
fb
thermo
fisher
scientif
co
incub
cell
line
use
herein
test
presenc
mycoplasma
use
mycoalert
mycoplasma
detect
kit
lonza
catalog
cell
viru
prepar
use
experi
mycoplasma
free
viru
prepar
prototyp
strain
belong
asian
genotyp
supplement
figur
isol
patient
dengu
shock
syndrom
thailand
strain
belong
genotyp
iib
supplement
figur
isol
patient
dengu
fever
indonesia
use
studi
cdna
initi
obtain
richard
kinney
arboviru
diseas
branch
center
diseas
control
prevent
fort
collin
colorado
usa
underw
minim
subsequ
passag
cell
laboratori
virus
grown
insect
cell
day
describ
elsewher
brief
cell
infect
either
moi
day
infect
cell
supernat
collect
store
denv
stock
titer
determin
limitingdilut
plaqu
assay
bhk
cell
describ
uvinactiv
prepar
irradi
viru
uv
lamp
minut
inch
viru
inactiv
confirm
plaqu
assay
bhk
cell
complet
genom
sequenc
isol
obtain
sequenc
overlap
rtpcr
product
length
use
viral
rna
purifi
dc
infect
templat
set
primer
pair
design
base
sequenc
avail
complet
genom
primer
includ
sequenc
univers
primer
gtaaaacgacggccagt
forward
primer
caggaaacagctatgac
revers
primer
facilit
sequenc
highfidel
rtpcr
perform
use
superscript
iii
highfidel
rtpcr
kit
invitrogen
condit
recommend
manufactur
rtpcr
product
purifi
agaros
gel
sequenc
use
univers
primer
final
complet
genom
manual
assembl
overlap
sequenc
upload
genbank
access
number
http
construct
phylogenet
tree
select
complet
genom
download
niaid
viru
pathogen
databas
analysi
resourc
websit
http
wwwviprbrc
org
select
manual
trim
contain
isol
repres
complet
genet
divers
sequenc
indonesia
strain
includ
consensu
neighborjoin
phylogenet
tree
replic
obtain
use
program
geneiou
http
wwwgeneiou
com
tree
visual
use
figtre
supplement
figur
denv
titrat
plaqu
assay
denv
infecti
particl
titrat
plaqu
assay
use
bhk
cell
standard
protocol
bhk
cell
seed
plate
cellswel
incub
overnight
co
follow
day
medium
remov
serial
dilut
viru
supernat
glutamax
ad
well
viru
inoculumwel
cell
incub
co
hour
follow
incub
overlay
consist
lowmeltingpoint
lonza
seaplaqu
agaros
distil
h
thermo
fisher
scientif
fb
mem
thermo
fisher
scientif
ad
mlwell
plate
incub
co
day
subsequ
remov
overlay
plaqu
fix
visual
crystal
violet
solut
ethanol
minut
gener
monocytederiv
dc
monocytederiv
dc
gener
buffi
coat
healthi
human
donor
new
york
blood
center
use
standard
protocol
briefli
peripher
blood
mononuclear
cell
isol
use
ficol
gradient
centrifug
histopaqu
sigmaaldrich
next
cell
isol
mononuclear
fraction
use
mac
isol
kit
miltenyi
biotech
accord
manufactur
instruct
cell
differenti
naiv
immatur
dc
incub
dc
media
rpmi
medium
mm
lglutamin
uml
penicillin
streptomycin
mm
sodium
pyruv
thermo
fisher
scientif
supplement
u
ml
human
granulocytemacrophag
colonystimul
factor
gmcsf
peprotech
uml
human
peprotech
vv
hyclon
fb
thermo
fisher
scientif
day
co
denv
infect
dc
day
cultur
donormatch
naiv
dc
infect
moi
treat
uvinactiv
viru
dc
medium
mock
minut
co
viru
adsorpt
viru
inoculum
remov
follow
centrifug
g
minut
dc
maintain
cultur
cellsml
dc
media
contain
fb
co
differ
time
period
depend
experi
infect
uvinactiv
denv
volum
uvinactiv
denv
ad
compar
infecti
denv
denv
infect
cell
subconflu
cell
cultur
plate
wash
pb
hour
seed
infect
denv
moi
pb
follow
incub
inoculum
remov
cell
wash
pb
return
cultur
media
incub
supernat
harvest
indic
time
point
titrat
bhk
cell
previous
describ
multiplex
elisa
cytokin
human
magnet
panel
luminex
platform
thermo
fisher
scientif
use
accord
manufactur
instruct
kit
detect
follow
cytokin
chemokin
gmcsf
eotaxin
rant
mig
data
acquir
luminex
system
analyz
standard
curv
fit
accord
manufactur
protocol
brief
analyt
dilut
seri
protein
standard
plu
assay
diluentonli
background
well
run
duplic
standard
curv
fit
use
weight
logist
function
protein
concentr
unknown
sampl
quantifi
standard
curv
duplic
averag
downstream
statist
analysi
standard
curv
model
perform
r
version
flow
cytometri
mockor
denvinfect
dc
first
incub
human
trustain
fcx
biolegend
follow
incub
use
livedead
fixabl
blue
dead
cell
stain
kit
thermo
fisher
scientif
accord
manufactur
instruct
cell
fix
permeabil
cytofix
cytoperm
bd
pharmingen
subsequ
stain
antidenv
monoclon
antibodi
gift
eva
harri
univers
california
berkeley
berkeley
california
usa
directli
conjug
dylight
thermo
fisher
scientif
sampl
run
lsrii
flow
cytomet
avail
mount
sinai
flow
cytometri
share
resourc
facil
data
analysi
perform
cytobank
softwar
version
cytobank
inc
cytof
stain
analysi
cytof
reagent
acquir
fluidigm
inc
unless
otherwis
indic
antibodi
either
purchas
preconjug
fluidigm
conjug
valid
inhous
use
maxpar
conjug
kit
fluidigm
inc
accord
manufactur
instruct
antibodi
clone
number
provid
supplement
tabl
viabil
stain
first
perform
mockor
denvinfect
dc
ad
nucleic
acid
intercal
directli
cell
cultur
media
indic
time
point
infect
incub
minut
sampl
wash
pb
contain
bsa
block
human
trustain
fcx
biolegend
incub
cocktail
titrat
maxpar
antibodi
cell
surfac
marker
supplement
tabl
minut
sampl
wash
mock
denvinfect
sampl
subsequ
fix
barcod
use
cellid
pd
barcod
kit
uniqu
barcod
id
assign
condit
time
point
barcod
sampl
pool
minim
stain
variabl
permeabil
use
bd
cytofixcytoperm
bd
bioscienc
incub
cocktail
maxpar
antibodi
intracellular
antigen
supplement
tabl
minut
sampl
wash
incub
nm
ir
nucleic
acid
intercal
enabl
cell
identif
base
dna
content
store
pb
contain
freshli
dilut
formaldehyd
electron
microscopi
scienc
acquisit
sampl
collect
hpi
time
point
store
combin
togeth
acquir
simultan
singl
barcod
sampl
minim
acquisit
batch
effect
immedi
prior
acquisit
barcod
sampl
wash
dih
resuspend
concentr
cell
per
ml
dilut
eq
element
bead
sampl
acquir
use
supersampl
fluidic
system
victorian
airship
event
rate
eventss
follow
data
acquisit
data
concaten
normal
use
softwar
barcod
sampl
deconvolut
use
matlabbas
debarcod
doubletfilt
applic
use
stringent
mahalanobi
distanc
cutoff
ensur
optim
barcod
separ
data
upload
cytobank
version
cytobank
inc
analysi
data
analyz
use
combin
manual
gate
approach
supplement
figur
autog
base
percentil
baselin
threshold
figur
supplement
figur
visn
figur
supplement
figur
manual
automat
gate
compar
advantag
disadvantag
could
accentu
high
dimension
cytof
data
although
current
standard
method
manual
gate
may
subject
oper
bia
choos
threshold
marker
posit
neg
wherea
autog
subject
bia
specifi
determinist
perfectli
reproduc
threshold
channel
hand
sensit
specif
autog
may
affect
data
qualiti
certain
analyt
assumpt
unexpect
presenc
outlier
data
could
skew
automat
calcul
threshold
wherea
expert
human
oper
would
abl
notic
correct
problem
util
type
analys
studi
pattern
cell
phenotyp
shown
gener
consist
either
method
supplement
figur
therefor
robust
choic
gate
techniqu
addit
visn
analysi
allow
visual
highdimension
singlecel
cytof
data
twodimension
plot
dimensionalityreduc
algorithm
phenotyp
chang
could
appreci
coordin
pattern
rel
posit
cell
plot
indic
gener
phenotyp
multidimension
space
stain
intens
indic
marker
display
express
level
gradient
visn
plot
gener
use
phenotyp
marker
cytof
panel
supplement
tabl
denv
e
protein
purpos
exclud
cluster
paramet
order
visual
distribut
infect
across
cellular
phenotyp
statist
data
multipl
dc
donor
signific
determin
use
pair
wilcoxon
signedrank
test
assum
normal
distribut
popul
benjaminihochberg
procedur
perform
time
point
cytokinechemokin
cytof
marker
adjust
signific
level
multipl
comparison
p
correct
multipl
comparison
consid
statist
signific
wilcoxon
signedrank
test
perform
prism
graphpad
softwar
benjaminihochberg
procedur
perform
r
version
event
count
manual
gate
cytof
data
export
cytobank
inc
autog
cytof
data
perform
set
threshold
percentil
distribut
observ
intens
marker
hpi
time
point
mocktreat
sampl
threshold
appli
time
point
treatment
donor
creat
event
count
posit
neg
subpopul
compar
effect
infect
condit
marker
express
calcul
within
donor
log
rel
risk
posit
marker
frequenc
live
popul
extract
time
point
marker
sinc
manual
gate
autog
strategi
determin
show
grossli
consist
pattern
supplement
figur
autog
use
extens
analys
figur
analys
marker
order
vertic
hierarch
cluster
median
log
rel
risk
marker
time
point
hierarch
cluster
perform
use
r
hclust
function
use
complet
agglomer
euclidean
distanc
row
vector
statist
signific
determin
use
fisher
exact
test
threshold
bonferroni
correct
multipl
test
similar
previou
analys
flow
cytometri
count
statist
analys
figur
perform
r
version
autog
implement
use
flowcor
flowstat
r
packag
bioconductor
version
respect
studi
approv
primari
human
cell
use
work
obtain
buffi
coat
new
york
blood
center
deidentifi
prior
distribut
new
york
blood
center
sampl
consid
nonhuman
subject
requir
institut
review
board
approv
